Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Albany Medical College
mi
from
Albany, NY
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Carteret Medical Group, LLC
mi
from
Morehead City, NC
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Carteret Medical Group, LLC
mi
from
Morehead City, NC
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
University Diabetes and Endocrine Consultants
mi
from
Chattanooga, TN
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
University Diabetes and Endocrine Consultants
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Aventiv Research- Phoenix
mi
from
Mesa, AZ
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Aventiv Research- Phoenix
mi
from
Mesa, AZ
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Pines Care Research Center, LLC
mi
from
Pembroke Pines, FL
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Pines Care Research Center, LLC
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Hanson Clinical Research Ctr
mi
from
Port Charlotte, FL
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Hanson Clinical Research Ctr
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Randolph Medical Associates
mi
from
Asheboro, NC
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Randolph Medical Associates
mi
from
Asheboro, NC
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Detweiler Family Medicine
mi
from
Lansdale, PA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Detweiler Family Medicine
mi
from
Lansdale, PA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
The Endocrine Center
mi
from
Houston, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
The Endocrine Center
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Bandera Family Health Clinic
mi
from
San Antonio, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Bandera Family Health Clinic
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Desert Oasis Healthcare Medical Group
mi
from
Palm Springs, CA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Desert Oasis Healthcare Medical Group
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
North America Research Institute Inc.
mi
from
San Dimas, CA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
North America Research Institute Inc.
mi
from
San Dimas, CA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Southeastern Clinical Research Institute, LLC
mi
from
Augusta, GA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Southeastern Clinical Research Institute, LLC
mi
from
Augusta, GA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research Center
mi
from
Anderson, IN
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research Center
mi
from
Anderson, IN
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Iowa Diabetes and Endocrinology Research
mi
from
West Des Moines, IA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Iowa Diabetes and Endocrinology Research
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
My Kidney Center, LLC
mi
from
Manhattan, KA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
My Kidney Center, LLC
mi
from
Manhattan, KA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Four Rivers Clincial Research
mi
from
Paducah, KY
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Four Rivers Clincial Research
mi
from
Paducah, KY
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Biolab Research, LLC
mi
from
Rockville, MD
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Biolab Research, LLC
mi
from
Rockville, MD
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Elite Research Center LLC
mi
from
Flint, MI
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Elite Research Center LLC
mi
from
Flint, MI
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Seacost Kidney & Hypertension
mi
from
Portsmouth, NH
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Seacost Kidney & Hypertension
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Wilmington Health
mi
from
Wilmington, NC
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Wilmington Health
mi
from
Wilmington, NC
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Brookview Hills Research
mi
from
Winston-Salem, NC
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Brookview Hills Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc./Oklahoma City Clinic
mi
from
Oklahoma City, OK
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc./Oklahoma City Clinic
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Knoxville Kidney Center PLLC
mi
from
Knoxville, TN
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Knoxville Kidney Center PLLC
mi
from
Knoxville, TN
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
The Medical Group of Texas
mi
from
Fort Worth, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
The Medical Group of Texas
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Houston Nephrology Research
mi
from
Houston, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Houston Nephrology Research
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Arizona Kidney Disease and Hypertension Center
mi
from
Flagstaff, AZ
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Arizona Kidney Disease and Hypertension Center
mi
from
Flagstaff, AZ
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Comprehensive Research Institute
mi
from
Alhambra, CA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Comprehensive Research Institute
mi
from
Alhambra, CA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Diabetes and Endocrinology Clinical Consultants of Texas
mi
from
Dallas, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Diabetes and Endocrinology Clinical Consultants of Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Effects of Exercise by Neuromuscular Stimulation in Dialysis Patients
Effects of Exercise Using Electrical Muscle Stimulation in End Stage Kidney Disease
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
Effects of Exercise by Neuromuscular Stimulation in Dialysis Patients
Effects of Exercise Using Electrical Muscle Stimulation in End Stage Kidney Disease
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes
Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 DiabetesL a Open-label Trial
Status: Enrolling
Updated:  12/31/1969
Barbara Davis Center for Diabetes
mi
from
Aurora, CO
Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes
Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 DiabetesL a Open-label Trial
Status: Enrolling
Updated: 12/31/1969
Barbara Davis Center for Diabetes
mi
from
Aurora, CO
Click here to add this to my saved trials
Improving Adherence in Renal Dialysis Patients Through Electronic Interventions
Improving Adherence in Renal Dialysis Patients; a Randomized Crossover Trial for an Electronic Intervention
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine @ Barnes-Jewish Hospital
mi
from
Saint Louis, MO
Improving Adherence in Renal Dialysis Patients Through Electronic Interventions
Improving Adherence in Renal Dialysis Patients; a Randomized Crossover Trial for an Electronic Intervention
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine @ Barnes-Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects
A Phase 2, Investigator-Initiated, Randomized, Double-Blind, Placebo-Controlled Study to Determine Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Subjects With Stage 4 and Stage 5 Kidney Disease
Status: Enrolling
Updated:  12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects
A Phase 2, Investigator-Initiated, Randomized, Double-Blind, Placebo-Controlled Study to Determine Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Subjects With Stage 4 and Stage 5 Kidney Disease
Status: Enrolling
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Smart Phone Medication Adherence Saves Kidneys--SMASK
Smart Phone Medication Adherence Saves Kidneys--SMASK
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Smart Phone Medication Adherence Saves Kidneys--SMASK
Smart Phone Medication Adherence Saves Kidneys--SMASK
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
AKI Management Using Electronic Alerts
Acute Kidney Injury: Integrating E-alerts and Clinical Decision Support System to Improve Outcomes
Status: Enrolling
Updated:  12/31/1969
Seattle Children's Hospital
mi
from
Seattle, WA
AKI Management Using Electronic Alerts
Acute Kidney Injury: Integrating E-alerts and Clinical Decision Support System to Improve Outcomes
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation
A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
mi
from
Madison, WI
A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation
A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Impact of Screening Patients With HIV for Kidney Disease
Impact of Screening Patients With HIV for Kidney Disease
Status: Enrolling
Updated:  12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Impact of Screening Patients With HIV for Kidney Disease
Impact of Screening Patients With HIV for Kidney Disease
Status: Enrolling
Updated: 12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
Pharmacokinetics of Lanabecestat (LY3314814) in Subjects With Impaired Renal Function
Status: Enrolling
Updated:  12/31/1969
Orange County Research Center
mi
from
Tustin, CA
A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
Pharmacokinetics of Lanabecestat (LY3314814) in Subjects With Impaired Renal Function
Status: Enrolling
Updated: 12/31/1969
Orange County Research Center
mi
from
Tustin, CA
Click here to add this to my saved trials
A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
Pharmacokinetics of Lanabecestat (LY3314814) in Subjects With Impaired Renal Function
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology of Miami
mi
from
Miami, FL
A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
Pharmacokinetics of Lanabecestat (LY3314814) in Subjects With Impaired Renal Function
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
Pharmacokinetics of Lanabecestat (LY3314814) in Subjects With Impaired Renal Function
Status: Enrolling
Updated:  12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
Pharmacokinetics of Lanabecestat (LY3314814) in Subjects With Impaired Renal Function
Status: Enrolling
Updated: 12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tempe, AZ
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Azusa, CA
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Azusa, CA
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Whittier, CA
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Whittier, CA
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Yuba City, CA
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Yuba City, CA
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Coral Gables, FL
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Hudson, FL
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hudson, FL
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pembroke Pines, FL
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials